2.7.1.171 Adenoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21253391&form=6&db=m Low red blood cell levels of deglycating enzymes in colorectal cancer patients. diagnostic usage,ongoing research,unassigned 4,4,0 2.7.1.171 Autoimmune Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28287856&form=6&db=m Enzymatic kinetics regarding reversible metabolism of CS-0777, a sphingosine 1-phosphate receptor modulator, via phosphorylation and dephosphorylation in humans. causal interaction,unassigned 2,0 2.7.1.171 Carcinogenesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31420355&form=6&db=m Deglycation of NRF2 by FN3K Promotes Oncogenesis and Drug Resistance. ongoing research,unassigned 1,0 2.7.1.171 Carcinogenesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34437174&form=6&db=m Deglycation of NRF2 by FN3K Promotes Oncogenesis and Drug Resistance. ongoing research,unassigned 1,0 2.7.1.171 Cataract http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33917258&form=6&db=m A Potential Role for Fructosamine-3-Kinase in Cataract Treatment. causal interaction,therapeutic application,unassigned 3,4,0 2.7.1.171 Colorectal Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18334852&form=6&db=m Gene expression of fructosamine 3 kinase in patients with colorectal cancer. causal interaction,diagnostic usage,ongoing research,unassigned 1,4,4,0 2.7.1.171 Colorectal Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21052529&form=6&db=m Reduced fructosamine-3-kinase activity and its mRNA in human distal colorectal carcinoma. diagnostic usage,ongoing research,unassigned 3,3,0 2.7.1.171 Diabetes Complications http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23648633&form=6&db=m A new HPLC-based assay for the measurement of fructosamine-3-kinase (FN3K) and FN3K-related protein activity in human erythrocytes. causal interaction,diagnostic usage,unassigned 3,1,0 2.7.1.171 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19834870&form=6&db=m A Polymorphism within the Fructosamine-3-kinase Gene is Associated with HbA1c Levels and the Onset of Type 2 Diabetes Mellitus. causal interaction,unassigned 3,0 2.7.1.171 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19834870&form=6&db=m A Polymorphism within the Fructosamine-3-kinase Gene is Associated with HbA1c Levels and the Onset of Type 2 Diabetes Mellitus. causal interaction,unassigned 3,0 2.7.1.171 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23492569&form=6&db=m Genetic variability in enzymes of metabolic pathways conferring protection against non-enzymatic glycation versus diabetes-related morbidity and mortality. therapeutic application,unassigned 1,0 2.7.1.171 Hyperglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32467223&form=6&db=m Role of fructosamine-3-kinase in protecting against the onset of microvascular and macrovascular complications in patients with T2DM. unassigned - 2.7.1.171 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31420355&form=6&db=m Deglycation of NRF2 by FN3K Promotes Oncogenesis and Drug Resistance. ongoing research,unassigned 1,0 2.7.1.171 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34437174&form=6&db=m Deglycation of NRF2 by FN3K Promotes Oncogenesis and Drug Resistance. ongoing research,unassigned 1,0 2.7.1.171 Macular Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32899850&form=6&db=m Fructosamine-3-Kinase as a Potential Treatment Option for Age-Related Macular Degeneration. therapeutic application,unassigned 4,0 2.7.1.171 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21253391&form=6&db=m Low red blood cell levels of deglycating enzymes in colorectal cancer patients. diagnostic usage,ongoing research,unassigned 4,4,0 2.7.1.171 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21319141&form=6&db=m Identification of a gene-expression signature for predicting lymph node metastasis in patients with early stage cervical carcinoma. therapeutic application,unassigned 1,0 2.7.1.171 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33466626&form=6&db=m The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers. causal interaction,ongoing research,therapeutic application,unassigned 4,2,1,0 2.7.1.171 protein-fructosamine 3-kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20009024&form=6&db=m Effects of fructosamine-3-kinase deficiency on function and survival of mouse pancreatic islets after prolonged culture in high glucose or ribose concentrations. causal interaction,ongoing research,unassigned 1,2,0